The global hip replacement implants market held US$ 7,202.5 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.6% during the forecast period from 2018 to 2026. The global hip replacement implants market is driven by growing volume of hip arthroplasty worldwide, development of dynamic implants with better compatibility and lower risk of infection, growing geriatric population susceptible for hip injuries and ailments. Alarming rise in the prevalence of osteoarthritis globally will augment the growth of hip replacement implants. According to Arthritis Foundation report of 2017, approximately 54.4 million adults is the U.S. had doctor-diagnosed arthritis, out of which 23.7 million had activity limitation due to the disease. The report also suggests that the number of doctor-diagnosed arthritis will increase 49 percent to 78.4 million by 2040 and close to 34.6 million patients will suffer for activity limitation due to arthritis. According to America Joint Replacement Registry (AJRR), in 2016, osteoarthritis was the most common reason for hip arthroplasty accounting for 70% of the overall cases in United States. Many studies suggest that hip replacement reduced pain, improved quality of life and overall healthcare resources utilization. Growing geriatric population is also driving the market for hip replacement implants. A study projects that more that 50% of total hip arthroplasty will be performed in patients younger than 70 by 2030. Technological advancement such as quality of material, enhancement in the life of the implant and overall patient outcome will continue to drive the market for hip replacement implants globally. For instance, Conformis, Inc. developed first 3D printed primary hip replacement system and successfully carried out its first surgery in U.S. in July 2018.
Market Synopsis
Get a sample copy for more information
"Femoral Reconstruction Implants Held the Largest Share"
In 2017, femoral reconstruction implants held the largest share in the global hip replacement implants market owing to large number of products available in the market. Though, femoral and acetabular reconstruction products are equally used in any hip replacement surgeries, the cost of the femoral reconstruction products are higher as compared to acetabular implants. Product innovation and growing number of hip arthroplasty globally are driving the market. Bearing and porous technologies will exhibit significant growth during the forecast period.
Get a sample copy for more information
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.
Get a sample copy for more information
Hip replacement implants market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product type, material, end-user and geography.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2016-2026 |
Base Year | 2017 |
Forecast Period | 2018-2026 |
Historical Year | 2016 |
Unit | USD Million |
Segmentation |
By Product Type (2016–2026; US$ Mn) |
By Material Type (2016–2026; US$ Mn) |
|
By End-User (2016–2026; US$ Mn) |
|
Geography Segment (2016–2026; US$ Mn) |
Market is studied in order to understand the current dynamics and future trends in the global hip replacement implants market. The study includes market size and forecast for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rate (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year. The key players currently engaged in hip replacement implants market include Zimmer Biomet Holdings, DePuy Synthes, Inc., Stryker Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Smith & Nephew Plc, DJO Global, Exactech, Inc. and Corin Orthopedics Holdings Ltd among others.